Literature DB >> 12433670

The epidemiology of severe sepsis in children in the United States.

R Scott Watson1, Joseph A Carcillo, Walter T Linde-Zwirble, Gilles Clermont, Jeffrey Lidicker, Derek C Angus.   

Abstract

Despite extensive research into the etiology and treatment of severe sepsis, little is known about its epidemiology in children. We sought to determine the age- and sex-adjusted incidence, outcome, and associated hospital costs of severe sepsis in United States children using 1995 hospital discharge and population data from seven states (24% of the United States population). Of 1,586,253 hospitalizations in children who were 19 years old or less, 9,675 met International Classification of Diseases, 9th revision, clinical modification-based severe sepsis criteria or 42,364 cases of pediatric severe sepsis per year nationally (0.56 cases per 1,000 population per year). The incidence was the highest in infants (5.16 per 1,000), fell dramatically in older children (0.20 per 1,000 in 10 to 14 year olds), and was 15% higher in boys than in girls (0.60 versus 0.52 per 1,000, p < 0.001). Hospital mortality was 10.3%, or 4,383 deaths nationally (6.2 per 100,000 population). Half of the cases had underlying disease (49.0%), and over one-fifth (22.9%) were low-birth-weight newborns. Respiratory infections (37%) and primary bacteremia (25%) were the most common infections. The mean length of stay and cost were 31 days and $40,600, respectively. Estimated annual total costs were 1.97 billion US dollars nationally. Severe sepsis is a significant health problem in children and is associated with the use of extensive healthcare resources. Infants are at highest risk, especially those with a low birth weight.

Entities:  

Mesh:

Year:  2002        PMID: 12433670     DOI: 10.1164/rccm.200207-682OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  231 in total

1.  Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis.

Authors:  Alex G Cuenca; James L Wynn; Kindra M Kelly-Scumpia; Philip O Scumpia; Lizette Vila; Matthew J Delano; Clayton E Mathews; Shannon M Wallet; Westley H Reeves; Kevin E Behrns; Dina C Nacionales; Philip A Efron; Steven L Kunkel; Lyle L Moldawer
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

3.  Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia.

Authors:  Ganesh Kumarachandran; Jennifer Kristie Johnson; Debbie-Ann Shirley; Eileen Graffunder; Emily L Heil
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

4.  Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals.

Authors:  Elizabeth K Goodman; Anne F Reilly; Brian T Fisher; Julie Fitzgerald; Yimei Li; Alix E Seif; Yuan-Shung Huang; Rochelle Bagatell; Richard Aplenc
Journal:  JAMA Pediatr       Date:  2014-10       Impact factor: 16.193

5.  Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.

Authors:  Jennifer Kaplan; Marchele Nowell; Ranjit Chima; Basilia Zingarelli
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

6.  Incidence of sepsis in hospitalized patients.

Authors:  Rui Moreno; Susana Afonso; Teresa Fevereiro
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

Review 7.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

Review 8.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.

Authors:  Derek S Wheeler; Basilia Zingarelli; William J Wheeler; Hector R Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-06

9.  A 7-year study of bloodstream infections in an English children's hospital.

Authors:  James W Gray
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

Review 10.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.